NeuroOne Medical announces it has been awarded a patent from the United States Patent and Trademark Office relating to its novel and proprietary electrode technology. The patent, titled "Improved Neural Depth Probes and Related Systems and Methods," adds to NeuroOne’s intellectual property portfolio, and is focused on a layered thin film neural depth electrode. The electrode could have potential applications in a wide variety of neurological procedures for both diagnostic and therapeutic use. Conditions that could potentially benefit from this technology include epilepsy, Parkinson’s disease, chronic back pain due to failed back surgeries, and mood- based disorders associated with depression, severe OCD, etc.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NMTC: